New EQA for 2020: Prediction of 5-Fluorouracil Toxicity (Testing of DPYD variants)

Posted 14/07/2020

GenQA are delighted to open registration for our latest new EQA.   This pilot EQA is open for all laboratories offering DPYD testing to predict toxicity in patients treated with 5-fluorouracil (5-FU) based chemotherapy.   For full details see https://www.genqa.org/eqa/687

Three DNA samples will be provided for analysis in October 2020, with four weeks for analysis. 

If you are interested in participating in this EQA but are not yet a member of GenQA, then please register to join GenQA.

Go to top